Latest Events

 

CPhI India 2019

Sami Labs participated in South Asia’s largest pharma event CPhI India 2019. The team exhibited its new innovative active ingredients & expertise in formulation manufacturing.

CPhI India 2019

Core products showcased during the event were : DigeZyme®, LactoSpore®, LactoSporin®, Tinofolin® , Sabeet®, Livinol™, Curcumin C3 Complex® & Curcumin C3 Reduct®.

CPhI India 2019

The company was represented by Mr. Mahesh LC, Mr. Paramveer Singh, Mr. Athul P. Mr Amandeep Sangra, Ms. Kaumudi Joshi, Mr. Kumar Mayank & Mr. Biplab Hazowary.

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019

CPhI India 2019
CPhI India 2019

Team Sami Labs in discussion with their prospective clients. Sami Labs recorded footfall of 250+ attendees at CPhI India 2019.

 

    HEADQUARTERS

  • Unit no.1200, 2nd Floor,
    Citiview Building
    12 Mac Dinh Chi Street
    Dakao Ward, District 1
    Hochiminh City 700000
    Vietnam

  • +84(28) 3930 0341
  • +84(28) 3930 0342
  • info@sabinsa.vn

CERTIFICATES

Certificate Logos Certificate Logos
Certificate Logos Certificate Logos

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.